Table 5 Unadjusted net benefit of the DAZT program relative to (baseline) conditions before the program using ORS and zinc coverage as the effectiveness measure
Variable | NB with λ = $0 | NB with λ = $2 | NB with λ = $4 | NB with λ = $6 | NB with λ = $8 | NB with λ = $10 |
|---|---|---|---|---|---|---|
Constant term | −3.72 [0.57] (0.00) | −3.70 [0.57] (0.00) | −3.69 [0.54] (0.00) | −3.67 [0.56] (0.00) | −3.66 [0.57] (0.00) | −3.65 [0.57] (0.00) |
Study phase | 0.12 [0.65] (0.43) | 0.46 [0.65] (0.24) | 0.80 [0.63] (0.10) | 1.15 [0.67] (0.04) | 1.49 [0.68] (0.01) | 1.83 [0.68] (0.00) |
Adjusted R-squared | −0.002 | −0.001 | 0.002 | 0.005 | 0.009 | 0.014 |
Wald chi-2 | 0.03 | 0.51 | 1.65 | 2.92 | 4.76 | 7.23 |
Prob > chi-2 | 0.852 | 0.474 | 0.199 | 0.088 | 0.029 | 0.007 |
AIC | 4079 | 4082 | 4093 | 4113 | 4140 | 4173 |
BIC | 4088 | 4090 | 4102 | 4121 | 4149 | 4182 |
y-hat-squared | 0.825 | 0.397 | 0.145 | 0.041 | 0.010 | 0.002 |
[Se] (p value) | ||||||